Chemokine receptors are considered to belong to the group of G protein-coupled receptors that use the first transmembrane domain as signal anchor sequence for membrane insertion instead of a cleavable N-terminal signal sequence. Chemokine recognition is determined by the N-termini of chemokine receptors. Here, we show that the chemokine receptor CCR7, which is essential for directed migration of adaptive immune cells, possesses a 24 amino acids long N-terminal signal sequence that is unique among chemokine receptors. This sequence is cleaved off the mature human and mouse protein. Introducing single point mutations in the hydrophobic core h-region or in the polar C-terminal segment (c-region) of the signal sequence to interfere with its cleavage retained CCR7 in the ER and prevented its surface expression. Furthermore, we demonstrate the correct topology of the 35 amino acids short extracellular N-tail of CCR7 in a deletion mutant lacking the natural signal sequence. This signal sequence deletion mutant of CCR7 is fully functional as it efficiently binds its ligand, elicits chemokine-induced calcium mobilization, and directs cell migration. However, we show that the signal sequence promotes efficient recruitment of the GPCR to ER exit sites, thereby controlling efficient ER to Golgi trafficking of CCR7 on its way to reach the plasma membrane.
INTRODUCTION
Chemokine signaling is crucial for coordinated cell migration in health and disease. 1 Typically chemokines signal through chemokine receptors belonging to the subfamily of rhodopsin-like (class A), G-protein coupled receptors (GPCRs) to orchestrate cell migration. 2 Structurally, chemokine receptors span the plasma membrane by 7 transmembrane -helices that are connected by 3 extracellular and 3 intracellular loops. The extracellular N-terminus of the receptor is linked through a disulfide bond to the third extracellular loop and considered to control chemokine binding and ligand specificity. 3, 4 Negatively charged amino acids of the receptor's N-terminus are generally thought to interact first with the basic core domain of the chemokine ligand, which posiAbbreviations: CCR7, CC chemokine receptor 7; COPII, coat protein complex II; ERES, endoplasmic reticulum exit site; ET B R, endothelin B receptor; GPCR, G protein-coupled receptor; RUSH, retention using selective hooks system; SBP, streptavidin-binding peptide; ss, signal sequence; TM, transmembrane domain tions the chemokine's N-terminus such that it facilitates its insertion into the binding pocked defined by the 7 transmembrane bundles of the receptor. [3] [4] [5] Chemokine receptors are highly dynamic structures and signaling efficiency principally relies on the discrete interaction with the chemokine ligand. 6 The chemokine receptor CCR7, together with its ligands CCL19 and CCL21, plays a crucial role in the guidance of the adaptive immune system. 1, 7, 8 CCR7 not only contributes to guiding early T cell progenitors through the thymus during T cell maturation, it also guides lymphoid tissue inducer cells required for the development of lymph nodes. Furthermore, CCR7 is essential in guiding antigen-bearing dendritic cells and lymphocytes into lymph nodes either from peripheral tissues via afferent lymphatics or from the blood circulation through high endothelial venules. Notably, misguidance of these leukocytes, for example, in CCR7 gene targeted mice or in plt/plt mice, a naturally occurring mouse strain lacking CCL19 and CCL21-Ser results in a defective adaptive immune response and can lead to the development of multi-organ autoimmune diseases. 7 Moreover, if expressed by cancer cells, CCR7 contributes to their dissemination, migration, and the formation of metastasis. 9 Given the importance of CCR7 and its ligands to the numerous processes, it is vital that this system is tightly regulated to ensure appropriate responses. Whereas inflammatory signals are known to induce and regulate CCR7 expression and migration in dendritic cells, 10, 11 posttranslational modifications of CCR7 emerge to critically regulate its activity. For instance, ubiquitylation of CCR7 has been found to control receptor trafficking and hence cell migration. 12 Tyrosine sulfation in the N-terminus of CCR7 was recently identified to significantly enhance CCL21 binding. 13 In addition, polysialylation of CCR7 was found to be essential for CCL21 recognition and hence dendritic cell homing to lymph nodes. 14 Moreover, we identified that distinct glycosylation patterns on CCR7's N-terminus and third extracellular loop shape receptor signaling and endocytosis to control leukocyte migration by CCL19 and CCL21. 15 Regulatory mechanisms underlying the complex expression and transport of multi-pass transmembrane GPCRs, and chemokine receptors in particular, to the plasma membrane are still relatively unexplored. 16, 17 The first step of intracellular transport of membrane proteins is the insertion into the ER membrane, which is mediated by signal sequences. Two distinct types of signal sequences are known for GPCRs. 18 The majority of GPCRs use the first transmembrane domain (TM) of the mature protein as non-cleavable signal anchor sequence, which directly binds to the signal recognition particle directing the ribosome and the nascent receptor to the ER membrane. In contrast, about 5-10% of GPCRs possess N-terminal signal sequences that are removed by signal peptidases during the translocon-mediated receptor insertion into the ER membrane. 19 Protein folding, membrane insertion, and assembly then occurs co-translationally. 20 Prior to the release of the complete receptor into the membrane interior, individual helices of incompletely synthesized GPCRs can be retained in the vicinity of the translocon with membrane integration of the nascent chain occurring only after several TM helices have been biosynthesized. 21 This provides one additional possibility to regulate surface expression.
The reason one group requires cleavable signal sequence whereas others do not is not really understood. 19 Chemokine receptors are thought to belong to the group of GPCRs using TM1 as signal anchor sequence. This is supported by studies using N-terminally epitope-tagged receptors for detection, which are not cleaved as exemplified for CCR2 22, 23 and CXCR4. 24, 25 In 1995, by comparing the N-terminal tails of a large collection of GPCRs, EBI1 was predicted to possess a cleavable signal sequence. 26 Upon identification of the chemokines CCL19 and CCL21 as ligands for EBI1, the receptor was renamed to CCR7. 27, 28 Although no one addressed it experimentally, it was originally speculated, but widely neglected in the chemokine field, that the putative cleaved signal sequence of EBI1/CCR7 comprising 24 amino acids was necessary for efficient posttranslational translocation of the remaining 35 amino acid short extracellular N-tail of the GPCR, which includes several positively charged residues. 26 Using SignalP, a state-of-the-art predictor of the presence and location of cleavable signal sequences, 29 we found that CCR7, but no other chemokine receptor, possesses a predicted cleavable signal sequence (Table 1) . In this study, we experimentally addressed whether CCR7 indeed possesses a unique cleavable signal sequence and whether the signal sequence regulates receptor surface expression and ligand binding.
MATERIALS AND METHODS

Plasmid constructs
The pcDNA3-based expression vector of human CXCR4 including an N-terminal HA-tag (YPYDVPDYA epitope following the start codon) was a kind gift of Adriano Marchese. 30 CXCR4 was replaced for human CCR7 to receive pcDNA3-HA-huCCR7 for the expression of an N-terminally HA-tagged human CCR7. 31 The plasmid mOrange2-Golgi-7 33 was purchased from Addgene (Cambridge, MA).
Cell lines and transfection
HeLa and HEK293 cells were cultured in DMEM (V.W.R.) supple- 
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Confocal microscopy
HEK293 cells stably expressing wildtype or mutant N-terminally HAtagged CCR7-GFP variants were grown overnight on 18 mm round coverslips (7.5 × 10 4 cells per well in a 12-well tissue culture plate).
Cells were washed with PBS and fixed with 3% Paraformaldehyde for 10 min at room temperature followed by permeabilization with 20 mM glycine, 0.2% Triton X-100 in PBS for 5 min at room temperature.
Cells were washed 3 times with PBS and incubated with a mouse primary antibody specific for Climp63 (diluted 1/1000 in PBS, 3%
BSA) for 1 h at room temperature. Cells were washed again followed 
RUSH system
Cells grown overnight on coverslips (7. 
Statistical data analysis
Nonparametric comparisons between unpaired data sets were analyzed by a two-tailed Mann-Whitney U test using GraphPad Prism 6 software. Error bars represent the SD. Box and Whiskers plots demonstrate the median and extreme values, as well as the 25th and 75th percentiles.
RESULTS
Identification of a unique signal sequence cleavage site for human and mouse CCR7
Chemokine receptors are considered to belong to the group of GPCRs that use the first TM as signal anchor sequence for membrane insertion and hence seem not to possess a cleavable N-terminal signal sequence. Moreover, the N-termini of chemokine receptors are generally considered as pivotal for binding their ligands. 3 Before it was recognized as chemokine receptor CCR7, EBI1 has been postulated to cleave off its putative N-terminal signal sequence from its mature protein. 26 Hence, we decided to determine whether the signal sequence of CCR7 is cleaved or not. We first exploited SinalP 3.0 (http://www.cbs.dtu.dk/services/SignalP-3.0/) 29, 35 to predict the presence and location of cleavable signal sequences in all classical chemokine receptors. These in silico sequence analyses of the Ntermini of human chemokine receptors revealed a cleavable signal sequence exclusively for CCR7 (UniProt ID: P32248 for human CCR7) with a P value of 0.990 and a maximal cleavage site P of 0.983 between residues Cys24 and Gln25 (Table 1 ; Fig. 1A ). The N-termini of any other classical chemokine receptor, including CXCR4 (UniProt ID: P61073-1, output graph for isoform 1 shown in Fig. 1A) , was predicted as non-cleavable (Table 1) . To experimentally address signal sequence cleavage, we cloned N-terminally HA-tagged human CCR7
and CXCR4, respectively, such that the tag precedes the corresponding signal sequence, and expressed them in HEK293 cells. Both the Nterminal HA-tag and CXCR4 were readily detected simultaneously at the surface of HEK293 cell transfectants by flow cytometry using HAtag-specific and CXCR4-specific antibodies (Fig. 1B) . These data confirm previous studies on N-terminally tagged CXCR4 24, 25 and clearly reveal that no parts of the N-terminus of CXCR4 are removed. In contrast, in cells expressing N-terminally HA-tagged CCR7, only a receptor specific antibody, but not the HA-tag-specific antibody was able to detect CCR7 at the cell surface (Fig. 1B) , providing first experimental evidence that CCR7 indeed possesses a signal sequence that is cleaved off the mature protein.
Correspondingly, SignalP 3.0 analysis of the N-termini of all classical mouse chemokine receptors (Table 1B) predicted a signal sequence with a P value of 0.961 and a cleavage site P of 0.959 between residues Cys24 and Gln25, which are conserved between mouse and human CCR7. To experimentally confirm signal sequence cleavage and additionally to identify the precise cleavage site, we generated FLAGtagged mouse CCR7 constructs, where the FLAG-tag was either fused to the N-terminal end of the predicted CCR7 precursor, termed FLAGss-CCR7, or directly after the predicted signal sequence and hence at the postulated immediate N-terminus of the mature CCR7, referred as ss-FLAG-CCR7 ( Fig. 2A) . Analogous to the results obtained for human CCR7, also mouse CCR7 possessed a cleavable signal sequence as we were able to surface stain CCR7, but not the N-terminal FLAG-epitope using specific antibodies in cells expressing FLAG-ss-CCR7 (Fig. 2B ).
In contrast, the FLAG-epitope was nicely detectable on the surface of cells expressing ss-FLAG-CCR7 (Fig. 2B) . Notably, a FLAG-tagged CCR7 construct has successfully been used previously 36 in which an artificial prolactin leader sequence and a FLAG epitope were fused to an N-terminally truncated mouse CCR7 (starting with amino acid 26 of the full-length protein). We next exploited the anti-FLAG antibody M1 which exclusively detects the FLAG-epitope when it is located at the free amino-terminus of a fusion protein. Expression of ss-FLAG-CCR7 and subsequent surface staining using the M1 antibody clearly revealed that the signal sequence of CCR7 consisting of the first 24 amino acids is cleaved off precisely after Cys24 from the precursor protein (Fig. 2C ).
Mutations within the h-and c-region of the signal sequence of CCR7 interferes with its surface expression
Signal sequences do not share a particular sequence identity but show a characteristic tripartite structure starting with a highly variable n-region, a central hydrophobic h-region, and a short polar c-region. 37 To further characterize the signal sequence of CCR7, we introduced mutations into the h-and c-region in N-terminally peptide-tagged mouse CCR7 (Fig. 3A) . We switched back to N-terminally HA-tagged CCR7 to avoid potential perturbation caused by the negatively charged amino acids of the FLAG-epitope. We detected surface expression of CCR7 using an anti-CCR7 antibody in HEK293 cells expressing HA-ss-CCR7 and ss-HA-CCR7 (Fig. 3B) . By contrast, the HA-epitope was only detectable at the surface of ss-HA-CCR7, but not of HA-ss-CCR7, transfected cells, suggesting that the signal sequence including the preceding HA-tag is cleaved off the mature protein (Fig. 3B) , confirming our previous findings with FLAG-tagged CCR7. To further investigate the role of the cleavable signal sequence in regulating CCR7 expression, we designed in silico mutants within the h-and c-region of the signal sequence of CCR7 that are predicted to become non-cleavable (Fig. 3A) . The cleavage probability determined by SignalP 3.0 of the wild-type N-terminus of CCR7 was 95.9%. Exchanging 1 (Cys24; CFK-CCR7) or 3 (Cys22,Leu23,Cys24; FFF-CCR7) polar amino acids in the c-region or 3 hydrophobic amino acids (Leu15,Leu16,Ile18;
hr-CCR7) within the h-region of the signal sequence reduced the cleavage probability to 1.8% for CFK-CCR7, 0.7% for FFF-CCR7, and 0% for hr-CCR7, respectively (Fig. 3A) . Using site-directed mutagenesis, we subsequently cloned and expressed N-terminally HA-tagged versions of these CCR7 variants in HEK293 cells. All 3 signal sequence mutants of CCR7 were barely expressed at the cell surface as determined by flow cytometry using a CCR7-specific antibody (Fig. 3B) , whereas HAss-CCR7 and ss-HA-CCR7 were readily detectable (Fig. 3B) . Moreover, the N-terminal HA-tag was readily detectable at the surface of cells expressing ss-HA-CCR7, but not HA-CFK-CCR7, HA-FFF-CCR7, or HA-hr-CCR7 (Fig. 3B) , suggesting that these mutants are not properly transported to the plasma membrane or are misfolded. To further examine their expression, we fused GFP to the C-terminus of these CCR7 variants. Although all transfected cells expressed GFP as a fusion protein, CCR7 was efficiently transported and expressed at the cell surface only in cells transfected with HA-ss-CCR7-GFP or ss-HA-CCR7-GFP (Fig. 3C ). These data suggest that mutating the h-and c-region of the cleavable signal sequence prevents surface expression of CCR7, but does not result in a completely misfolded protein as the GFP fused to the C-terminus of the receptor variants was detectable through its fluorescence.
The signal sequence of CCR7 is dispensable for functional surface expression
Next, we aimed to determine whether the cleavable signal sequence is required for CCR7 surface expression. To this end, we deleted the first 24 amino acids of the CCR7 precursor. Expression of this Δss-HA-CCR7 in HEK293 cells was readily detected at the cell surface, but had a slightly reduced expression level in stable transfectants when compared to ss-HA-CCR7, which includes the signal sequence (Fig. 3D) . To test their functionality, we first determined ligand binding to the receptor variants. ss-HA-CCR7 and Δss-HA-CCR7 displayed similar binding capacities for a recombinant Fc-tagged CCL19 31 that correlated with their expression at the cell surface (Fig. 3D) . Next, we stably expressed both constructs in the lymphocytic cell line 300-19 commonly used for functional characterization of chemokine receptors. 28, 38 Cell lines expressing similar levels of surface CCR7 were subjected to graded concentrations of CCL19 or CCL21 in Transwell migration assays. The efficiency and efficacy of chemokine-mediated cell migration did not substantially differ in cells expressing Δss-HA-CCR7 or ss-HA-CCR7 (Fig. 3E) . In addition, stimulation of these two cell lines with CCL19 or CCL21 resulted in comparable transient elevations of intracellular Ca 2+ concentrations (Fig. 3F) . These data provide clear evidence that the cleavable signal sequence is dispensable for functional surface expression of CCR7. This is unexpected as the signal sequence of EBI1/CCR7 was originally proposed to facilitate efficient N-tail translocation. 26 The HA-epitope is fully accessible at the cell surface of transient transfectants expressing Δss-HA-CCR7-GFP, demonstrating that the N-terminus is correctly translocated across the membrane (Fig. 4A ).
CCR7 with mutated signal sequence is retained in the ER
Our data demonstrate that the signal sequence of CCR7 is dispensable for functional expression, whereas mutations aimed to prevent its cleavage hampered its surface expression (Figs. 3 and 4A ). This prompted us to further investigate the intracellular localization of our CCR7 variants in stable transfected HEK293 cells by confocal microscopy. In line with our flow cytometric results, we found CCR7-GFP to be predominantly expressed at the plasma membrane of cells expressing either HA-ss-CCR7-GFP, ss-HA-CCR7-GFP, or Δss-HA-CCR7-GFP (Fig. 4B) . We also detected CCR7-GFP in vesicular structures, presumably of the secretory pathway. In fact, intracellular CCR7-GFP partially co-localized with the ER marker Climp63 (Fig. 4B) and with TGN46. 12 By contrast, HA-CFK-CCR7-GFP with a single codon mutation within the c-region of the cleavable signal sequence was barely detected at the plasma membrane ( Fig. 4A and B) and predominantly expressed in intracellular compartments, where it colocalized with Climp63 (Fig. 4B) . These findings provide evidence that interfering with cleavage of the signal sequence results in ER retention of CCR7.
concentrations of CCL19 or CCL21 in Transwell chemotaxis assays. Percent of specific cell migration towards CCR7 ligands is shown as mean ± SD derived from n = 4 (for 0, 100, and 500 ng/ml CCL19), n = 3 (for 20 ng/ml CCL19 and 0, 5, 20, 100, and 2000 ng/ml CCL21), n = 2 (for 5 ng/ml CCL19 and 500 ng/ml CCL21), and n = 1 (for 2000 ng/ml CCL19). . The box extends from the 25th to 75th percentiles (Fig. 5A ). Interestingly, a significantly lower pool of ER-released Δss-CCR7-RUSH-GFP reached the Golgi after 10 min of biotin treatment and remained ER associated to a considerable extent ( Fig. 5A and B). Quantification of coincidence, calculated as ratio of receptor present in the Golgi area from cells with similar mean GFP expression levels and containing definable Golgi structures, revealed significantly higher Golgi association of ss-CCR7-RUSH-GFP compared to
Δss-CCR7-RUSH-GFP (Fig. 5B) . A maximum of 1.9-fold higher Golgi association for ss-CCR7-RUSH-GFP was found 10 min after biotin addition, decreasing to a constant value of approximately 1.5-fold higher Golgi association after 30 or 60 min of trafficking (Fig. 5B) .
Confocal live-cell imaging in HeLa coexpressing the orange fluorescent trans-Golgi marker Golgi-7 together with either ss-CCR7-RUSH-GFP or Δss-CCR7-RUSH-GFP revealed a significantly faster onset for ss-CCR7-RUSH-GFP (median: 180 s) with the Golgi than for Δss-CCR7-RUSH-GFP (median: 360 s) (Fig. 5C) . Altogether, these observations suggest a weak, but significant ER-to-Golgi trafficking defect of Δss-CCR7-RUSH-GFP.
The signal sequence promotes efficient recruitment of CCR7 to ER exit sites
Since Δss-CCR7-RUSH-GFP was delayed in ER-to-Golgi trafficking and showed no tendency to "catch up" with the ss-CCR7-RUSH-GFP over 1 h of trafficking (Fig. 5B) , we wondered whether this differential behavior of the mutant receptor lacking the signal sequence emerges already at an early step close to ER exit. Secretory protein transport from the ER to the Golgi is mediated by COPII-vesicles 40 known to participate in regulating GPCR export trafficking. 41 (Fig. 6A) , which was significantly lower for Δss-CCR7-RUSH-GFP (Fig. 6B ). This indicates a defect of sorting Δss-CCR7 into ERES, which is in accordance with the finding that this mutant exhibits defects in trafficking.
Altogether, we demonstrate that CCR7 possesses a unique Nterminal signal sequence comprising 24 amino acids which appears to promote maturation of the GPCR and sorting into ERES for efficient cargo delivery to the plasma membrane.
DISCUSSION
Chemokine receptors sense chemokine gradients to guide cell migration in space and time in a highly organized and tightly regulated manner. Thereby, a controlled and timely expression of the receptor . Mean values ± SD (n.s., not statistically significant; ****P < 0.0001) derived from n = 3 independent experiments were analyzed by a two-tailed Mann-Whitney U test is critical for chemokine recognition. The initial interaction between a chemokine and its cognate receptor occurs in 2 major steps that seem to be consistent among all chemokine receptors, whereas several additional intermediate interactions have been described for specific chemokines. Overall, the N-terminus of the receptor is essential for the first step of chemokine binding. 3, 4 Consistent with this paradigm, an N-terminal peptide of CCR7 was found to bind to the N-loop and the third -strand of CCL21, 43 whereas binding to CCL19 was not addressed in that study.
Here, we identify a unique cleavable N-terminal signal sequence for CCR7. All other chemokine receptors, as most other GPCRs, lack such a cleavable N-terminal signal sequence and use a signal anchor sequence in TM1 for membrane insertion and subsequent export for surface expression. Only a minority of GPCRs possesses cleavable N-terminal signal sequences, which fulfill distinct critical functions. 18, 19 For instance, the cleavable signal sequence of the class A GPCR protease-activated receptor 1 is required for its expression. 44 The signal sequence of the endothelin B receptor ET B R, another class A of GPCRs, was shown to be necessary for the translocation of the receptor's N-terminal tail across the ER membrane. 45 Furthermore, cleavage of the signal sequence was found to be obligatory for the processing and trafficking to the cell surface of the class B GPCR glucagon-like peptide-1. 46 Our study reveals that the signal sequence of CCR7 is not essential for biosynthesis, membrane insertion, and transport of this receptor to the plasma membrane. However, using the signal sequence deletion mutant Δss-CCR7, we demonstrated that the signal sequence controlled a fast recruitment of CCR7 into ERESs, facilitating efficient CCR7-containing COPII-vesicle trafficking from the ER to the Golgi. As the Δss-CCR7 mutant was still able to reach the plasma membrane, TM1 is likely to serve as a functional internal signal anchor sequence. 47, 48 This notion is supported by our finding that an N-terminal epitope tag fused to Δss-CCR7 was readily detectable at the cell surface pointing to an efficient posttranslational translocation of the remaining 35 residues short N-tail of the receptor across the membrane. Here, we report that the signal sequence of CCR7 is dispensable for its insertion into the ER membrane, but appears to promote maturation of the receptor and sorting into ERES for efficient receptor trafficking, a function which, to the best of our knowledge, has not been reported for any other GPCR yet.
A wide range of post-targeting functions of signal sequences have been described, 49 such as interaction with the translocon 50 or regulation of the ribosome-translocon junction. 51 Interestingly, the sequence following the signal sequence of ET B R is known to be required for efficient translocon gating at the ER membrane. 52 We identified critical residues within the h-and c-region of the signal sequence of CCR7. Mutating these residues impaired CCR7 trafficking to the plasma membrane due to retention in the ER, where the signal sequence is most probably not removed from the fully syn- The CCR7 mutant lacking the signal sequence showed a mild, but significant sorting defect, resulting in a subsequent retarded release from the ER as evidenced from RUSH experiments.
Besides affecting targeting efficiency, signal sequences can influence the timing of cleavage from secreted glycoproteins by signal peptidase, which is thought to control N-glycosylation 54 and provides a high-affinity ligand for the translocon-associated membrane chaperone calnexin. As CCR7 is known to be glycosylated, 15 it is tempting to speculate that membrane bound calnexin might assist the correct folding and maturation process of CCR7 to prevent export of premature cargo and to achieve an export-competent protein ready to be recruited into ER-derived COPII transport vesicles. 55, 56 In fact, correct glycosylation and polysialylation of CCR7 controls chemokine recognition and discrete signal transduction. 14, 15 Finally, we would like to point out that the identification of a cleavable signal sequence of CCR7 is critical for the design of peptides to generate antibodies for detection. Synthetic peptides covering the Ntermini of chemokine receptors in general have regularly been used for immunization and raising antibodies. Available antibodies might, therefore, be re-evaluated to ensure that they detect the mature form of CCR7 and not a non-cleaved precursor. Moreover, our finding also needs to be considered for the design and development of validated new antibodies against CCR7 for numerous applications and for a successful epitope-tagging of the receptor. 
